2 followers
Pyxis Oncology is advancing a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to help patients suffering from difficult-to-treat cancers.
Lara S. Sullivan
Gameto
4 followers
Synthekine
3 followers
Tango Therapeutics
2 followers
Vera Therapeutics
2 followers
Kyverna Therapeutics
7 followers
Apogee Therapeutics
1 follower
Cargo
1 follower
Aura Biosciences
1 follower
Edgewise Therapeutics
1 follower
Cartesian Therapeutics
1 follower
Aviceda Therapeutics
1 follower
Explore companies